Mitochondria are vital to energy production in cells and so play a key role in fueling cancer growth. However, how mitochondrial DNA (mtDNA) contributes to cancer has been unclear.
Jan 2, 2025
0
61
Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international institutions, found significant associations between diet and colorectal cancer risk. Examining data from ...
Since its discovery in the 1990s, programmed cell death protein 1 (PD-1) has been regarded as a leading target in cancer treatments. A checkpoint receptor that often resides on the surface of immune system cells, the PD-1 ...
Jan 3, 2025
0
63
Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, including cancer cells developing ...
Dec 23, 2024
0
162
Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%.
Jan 21, 2025
0
39
A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.
Jan 3, 2025
0
41
Cancer is a deadly disease taking the lives of thousands of people worldwide, and researchers are constantly looking for better alternatives for treatment. One of the major breakthroughs is combination therapy—a treatment ...
Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Jan 13, 2025
0
67
Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening for people at high risk of developing the disease, and researchers are collaborating to develop ...
Dec 29, 2024
0
5
A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly ...
Jan 16, 2025
0
64
